» Articles » PMID: 33281995

Joint Models for Time-to-Event Data and Longitudinal Biomarkers of High Dimension

Overview
Journal Stat Biosci
Date 2020 Dec 7
PMID 33281995
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

Joint models for longitudinal biomarkers and time-to-event data are widely used in longitudinal studies. Many joint modeling approaches have been proposed to handle different types of longitudinal biomarkers and survival outcomes. However, most existing joint modeling methods cannot deal with a large number of longitudinal biomarkers simultaneously, such as the longitudinally collected gene expression profiles. In this article, we propose a new joint modeling method under the Bayesian framework, which is able to analyze longitudinal biomarkers of high dimension. Specifically, we assume that only a few unobserved latent variables are related to the survival outcome and the latent variables are inferred using a factor analysis model, which greatly reduces the dimensionality of the biomarkers and also accounts for the high correlations among the biomarkers. Through extensive simulation studies, we show that our proposed method has improved prediction accuracy over other joint modeling methods. We illustrate the usefulness of our method on a dataset of idiopathic pulmonary fibrosis patients in which we are interested in predicting the patients' time-to-death using their gene expression profiles.

Citing Articles

Dynamic and concordance-assisted learning for risk stratification with application to Alzheimer's disease.

Li W, Li R, Feng Z, Ning J Biostatistics. 2024; 26(1).

PMID: 39255368 PMC: 11823260. DOI: 10.1093/biostatistics/kxae036.


A latent variable approach to jointly modeling longitudinal and cumulative event data using a weighted two-stage method.

Abbott M, Nahum-Shani I, Lam C, Potter L, Wetter D, Dempsey W Stat Med. 2024; 43(21):4163-4177.

PMID: 39030763 PMC: 11338709. DOI: 10.1002/sim.10171.


Gaussian variational approximate inference for joint models of longitudinal biomarkers and a survival outcome.

Tu J, Sun J Stat Med. 2022; 42(3):316-330.

PMID: 36443903 PMC: 10099947. DOI: 10.1002/sim.9619.

References
1.
Faucett C, Thomas D . Simultaneously modelling censored survival data and repeatedly measured covariates: a Gibbs sampling approach. Stat Med. 1996; 15(15):1663-85. DOI: 10.1002/(SICI)1097-0258(19960815)15:15<1663::AID-SIM294>3.0.CO;2-1. View

2.
Herazo-Maya J, Noth I, Duncan S, Kim S, Ma S, Tseng G . Peripheral blood mononuclear cell gene expression profiles predict poor outcome in idiopathic pulmonary fibrosis. Sci Transl Med. 2013; 5(205):205ra136. PMC: 4175518. DOI: 10.1126/scitranslmed.3005964. View

3.
ANDERSON J, Cain K, Gelber R . Analysis of survival by tumor response. J Clin Oncol. 1983; 1(11):710-9. DOI: 10.1200/JCO.1983.1.11.710. View

4.
Carvalho C, Chang J, Lucas J, Nevins J, Wang Q, West M . High-Dimensional Sparse Factor Modeling: Applications in Gene Expression Genomics. J Am Stat Assoc. 2011; 103(484):1438-1456. PMC: 3017385. DOI: 10.1198/016214508000000869. View

5.
Ghosh J, Dunson D . Default Prior Distributions and Efficient Posterior Computation in Bayesian Factor Analysis. J Comput Graph Stat. 2013; 18(2):306-320. PMC: 3755784. DOI: 10.1198/jcgs.2009.07145. View